Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


06. January 2021 | 17:30 CET

Palantir, Silver Viper, TUI - the timing is crucial!

  • Investments
Photo credits: pixabay.com

Gold and silver are bullish again. While the two precious metals provided investors with returns of 20% in each of the past two years, the trend stalled somewhat from August onwards. The correction was due to brightening sentiment regarding the Corona pandemic, significant successes in vaccine research, and the voting out of the Donald Trump administration in the United States. What remains, however, is the sharp rise in sovereign debt issues and extremely low interest rates.

time to read: 3 minutes by Stefan Feulner


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


Fallen pearls

Both gold and silver stocks suffered sometimes heavy losses in line with the precious metals themselves. For most companies, however, these losses by no means reflect the fundamentals. For example, junior explorer Silver Viper is proceeding like clockwork. The Company explores for gold and silver in Sonora, Mexico and is currently operating its La Virginia gold-silver project, which was once owned by Pan American Silver Corp. The former owners had previously drilled 188 holes totalling 52,000 meters between 2010 and 2012. Silver Viper is using this historical data to define new target drilling. High-grade precious metal grades have been identified in the El Rubi zone in recent months.

Further path secured

As a result of a capital increase completed last fall, there is nearly CAD 3.5 million in the Canadians' savings account as of the end of December 2020. In mid-December, very positive news came confirming the El Rubi zone's high silver and gold grades. Further drilling showed a southern extension of the mineralized zone as well as the continuation of existing mineralization trends. Furthermore, management reported that test results should also indicate a high recovery rate of precious metals. With the excellent cash cushion, the Company will significantly expand exploration work for 2021. At the moment, Silver Viper shares, which are also traded in Germany, are available for CAD 0.48. Before the correction, the value was still at CAD 0.85. The stock market value is just under EUR 16.0 million.

New chance with Big Brother

Data is the gold of the 21st century. Based on this, Palantir could be categorized as a gold explorer. The US software developer based in Palo Alto, California, specializes in so-called data mining, prospecting for data, and the analysis and storage of large amounts of data. After a brilliant stock market debut, things went steeply upwards for the Big Data specialist. From under USD 10.0, the value rose to a peak of USD 33.0. The subsequent correction then led back to the support area at USD 22.0. If one looks at the abundance of high-ranking customers' orders, this level should offer an exciting buying opportunity.

Clients of the best kind

The US clients are among the top players in both the public and private sectors. In addition to collaborations with intelligence agencies such as the CIA and NSA, and the US military, the US announced the signing of a multi-million dollar, three-year contract with the US Food and Drug Administration. Closer cooperation with Greece was also agreed. Yesterday, a USD 22.5 million one-year contract was signed with Japanese firm SOMPO Holdings for the "Real Data Platform for Security, Health and Wellbeing." Palantir is still deep in the red. However, the Company is unique in its end-to-end platform and data integration, visualization and analysis. Therefore, another multiplication would not come as a surprise.

Another injection

The German government has already given financial aid to TUI twice before. In April, the development bank KfW granted the Group a loan of EUR 1.8 billion. In August the tourism giant agreed with Berlin on a different stabilization package totalling EUR 1.2 billion. However, due to the ongoing Corona pandemic and the loss of winter business, this is not enough. The state is now increasing by a further EUR 1.3 billion.

Major shareholder stands ready

With the third package, shareholders are shouldering part of the aid for the first time. The new share certificates can be subscribed to in Germany from January 8 at a price of EUR 1.07. As the issue price is below the previous nominal value of EUR 2.56, TUI had to reduce the share capital for the capital increase. Should not enough shareholders or private investors take hold of the stock, which has collapsed due to the crisis, the Russian TUI major shareholder Alexej Mordaschow would increase its stake from currently just under 25 to up to 36 percent. The financial supervisory authority BaFin exempted his Company Unifirm from the obligation to make a takeover bid to all shareholders if the threshold of 30 percent is exceeded.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read